PELOTON THERAPEUTICS Trademark

Trademark Overview


On Tuesday, December 11, 2018, a trademark application was filed for PELOTON THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PELOTON THERAPEUTICS trademark a serial number of 88225205. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, February 14, 2022. This trademark is owned by Peloton Therapeutics, Inc.. The PELOTON THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical preparations for the treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension and inflammatory bowel disease; Pharmaceutical preparations for use in the field of oncology; pharmaceutical preparations, namely, medicines for human consumption taken orally for treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension, inflammatory diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies

Pharmaceutical research and development services for research and development of human pharmaceutical preparations
peloton therapeutics

General Information


Serial Number88225205
Word MarkPELOTON THERAPEUTICS
Filing DateTuesday, December 11, 2018
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, February 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 14, 2019

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension and inflammatory bowel disease; Pharmaceutical preparations for use in the field of oncology; pharmaceutical preparations, namely, medicines for human consumption taken orally for treatment of cancerous diseases, inflammation, metabolic diseases, pulmonary hypertension, inflammatory diseases; pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-inflammatories, anti-virals, anti-infectives, immunosuppressants and pharmaceutical antibodies
Disclaimer with Predetermined Text"THERAPEUTICS"
Goods and ServicesPharmaceutical research and development services for research and development of human pharmaceutical preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, January 3, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, January 3, 2019
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NamePeloton Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDallas, TX 752357323

Party NamePeloton Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDallas, TX 752357323

Trademark Events


Event DateEvent Description
Monday, February 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, February 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, January 18, 2022ASSIGNED TO EXAMINER
Friday, July 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 7, 2021EXTENSION 4 GRANTED
Wednesday, July 7, 2021EXTENSION 4 FILED
Wednesday, July 7, 2021TEAS EXTENSION RECEIVED
Thursday, June 10, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 10, 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, June 10, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 10, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, January 1, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 30, 2020EXTENSION 3 GRANTED
Wednesday, December 30, 2020EXTENSION 3 FILED
Wednesday, December 30, 2020TEAS EXTENSION RECEIVED
Saturday, June 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 25, 2020EXTENSION 2 GRANTED
Thursday, June 25, 2020EXTENSION 2 FILED
Thursday, June 25, 2020TEAS EXTENSION RECEIVED
Friday, May 1, 2020ASSIGNED TO EXAMINER
Saturday, January 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2020EXTENSION 1 GRANTED
Thursday, January 9, 2020EXTENSION 1 FILED
Thursday, January 9, 2020TEAS EXTENSION RECEIVED
Friday, November 8, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, November 8, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, October 22, 2019WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, October 22, 2019TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, July 9, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 14, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2019PUBLISHED FOR OPPOSITION
Wednesday, April 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sunday, March 31, 2019ASSIGNED TO LIE
Tuesday, March 12, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 12, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, March 12, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, March 12, 2019EXAMINERS AMENDMENT -WRITTEN
Friday, March 8, 2019ASSIGNED TO EXAMINER
Thursday, January 3, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 14, 2018NEW APPLICATION ENTERED IN TRAM